These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 1650002)
1. A method for preparation of liposomes with encapsulated peptide antigens and surface-linked sugar residues. Weissig V; Lasch J; Gregoriadis G Pharmazie; 1991 Jan; 46(1):56-7. PubMed ID: 1650002 [No Abstract] [Full Text] [Related]
2. Recognition of novel amphiphiles with many pendent mannose residues by Con A. Tagawa K; Sendai N; Ohno K; Kawaguchi T; Kitano H; Matsunaga T Bioconjug Chem; 1999; 10(3):354-60. PubMed ID: 10346864 [TBL] [Abstract][Full Text] [Related]
3. Incorporation of peptides in phospholipid aggregates using ultrasound. Silva R; Little C; Ferreira H; Cavaco-Paulo A Ultrason Sonochem; 2008 Sep; 15(6):1026-32. PubMed ID: 18467154 [TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen. Jackson DC; Brown LE Pept Res; 1991; 4(3):114-24. PubMed ID: 1823182 [TBL] [Abstract][Full Text] [Related]
6. Recognition of novel lipopolypeptides with many pendent sugar residues by lectin. Kitano H; Sumi Y; Tagawa K Bioconjug Chem; 2001; 12(1):56-61. PubMed ID: 11170366 [TBL] [Abstract][Full Text] [Related]
7. Mimicry of viral epitopes with retro-inverso peptides of increased stability. Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant. Jérôme V; Graser A; Müller R; Kontermann RE; Konur A J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372 [TBL] [Abstract][Full Text] [Related]
9. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946 [TBL] [Abstract][Full Text] [Related]
10. Synthetic peptides as functional mimics of a viral discontinuous antigenic site. Villén J; Borràs E; Schaaper WM; Meloen RH; Dávila M; Domingo E; Giralt E; Andreu D Biologicals; 2001; 29(3-4):265-9. PubMed ID: 11851326 [TBL] [Abstract][Full Text] [Related]
12. Immunopotency of a viral peptide assembled on the carbohydrate moieties of self immunoglobulins. Brumeanu TD; Casares S; Harris PE; Dehazya P; Wolf I; von Boehmer H; Bona CA Nat Biotechnol; 1996 Jun; 14(6):722-5. PubMed ID: 9630978 [TBL] [Abstract][Full Text] [Related]
13. Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes. Beck Z; Karasavvas N; Matyas GR; Alving CR J Drug Target; 2008 Aug; 16(7):535-42. PubMed ID: 18686123 [TBL] [Abstract][Full Text] [Related]
14. [Study on preparation of ampelopsin liposomes]. He ZF; Liu DY; Zeng S; Ye JT Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):27-30. PubMed ID: 18338614 [TBL] [Abstract][Full Text] [Related]
15. Analysis of peptide and lipopeptide content in liposomes. Lutsiak ME; Kwon GS; Samuel J J Pharm Pharm Sci; 2002; 5(3):279-84. PubMed ID: 12553897 [TBL] [Abstract][Full Text] [Related]
17. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Espuelas S; Thumann C; Heurtault B; Schuber F; Frisch B Bioconjug Chem; 2008 Dec; 19(12):2385-93. PubMed ID: 19053315 [TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies. Sakai K; Shimizu Y; Chiba T; Matsumoto-Takasaki A; Kusada Y; Zhang W; Nakata M; Kojima N; Toma K; Takayanagi A; Shimizu N; Fujita-Yamaguchi Y Biochemistry; 2007 Jan; 46(1):253-62. PubMed ID: 17198396 [TBL] [Abstract][Full Text] [Related]
19. Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells. Nygard NR; Giacoletto KS; Bono C; Gorka J; Kompelli S; Schwartz BD J Immunol; 1994 Feb; 152(3):1082-93. PubMed ID: 8301118 [TBL] [Abstract][Full Text] [Related]
20. Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route. Montaner AD; De Nichilo A; Elias F; Rodríguez JM; Fló JM; López RA; Zorzopulos J; Frank R Vaccine; 2006 Mar; 24(11):1889-96. PubMed ID: 16343699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]